SI2976084T1 - Kombinacija, ki vsebuje zidovudin in prolimiksin - Google Patents
Kombinacija, ki vsebuje zidovudin in prolimiksinInfo
- Publication number
- SI2976084T1 SI2976084T1 SI201431590T SI201431590T SI2976084T1 SI 2976084 T1 SI2976084 T1 SI 2976084T1 SI 201431590 T SI201431590 T SI 201431590T SI 201431590 T SI201431590 T SI 201431590T SI 2976084 T1 SI2976084 T1 SI 2976084T1
- Authority
- SI
- Slovenia
- Prior art keywords
- zidovudine
- polymyxin
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1305277.4A GB201305277D0 (en) | 2013-03-22 | 2013-03-22 | Novel combination and use |
EP14714773.0A EP2976084B1 (en) | 2013-03-22 | 2014-03-20 | Combination comprising zidovudine and polymyxin |
PCT/GB2014/050878 WO2014147405A1 (en) | 2013-03-22 | 2014-03-20 | Combination comprising zidovudine and polymyxin |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2976084T1 true SI2976084T1 (sl) | 2020-10-30 |
Family
ID=48226873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201431590T SI2976084T1 (sl) | 2013-03-22 | 2014-03-20 | Kombinacija, ki vsebuje zidovudin in prolimiksin |
Country Status (15)
Country | Link |
---|---|
US (1) | US9757427B2 (sl) |
EP (1) | EP2976084B1 (sl) |
JP (1) | JP6444370B2 (sl) |
CN (1) | CN105120870B (sl) |
CA (1) | CA2906263C (sl) |
DK (1) | DK2976084T3 (sl) |
ES (1) | ES2795294T3 (sl) |
GB (1) | GB201305277D0 (sl) |
HK (1) | HK1216716A1 (sl) |
HR (1) | HRP20200938T1 (sl) |
HU (1) | HUE050652T2 (sl) |
PL (1) | PL2976084T3 (sl) |
PT (1) | PT2976084T (sl) |
SI (1) | SI2976084T1 (sl) |
WO (1) | WO2014147405A1 (sl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190111067A1 (en) | 2014-12-18 | 2019-04-18 | Helperby Therapeutics Limited | Antimicrobial combinations and their use in the treatment of microbial infection |
US10335454B2 (en) | 2014-12-18 | 2019-07-02 | Helperby Therapeutics Limited | Combination and use |
GB201521771D0 (en) | 2015-12-10 | 2016-01-27 | Helperby Therapeutics Ltd | Formulation |
SE540411C2 (en) | 2016-01-27 | 2018-09-11 | Ultupharma Ab | New method of treating bacterial infections |
GB201610869D0 (en) | 2016-06-22 | 2016-08-03 | Helperby Therapeutics Ltd | Combination |
GB201612093D0 (en) | 2016-07-12 | 2016-08-24 | Helperby Therapeutics Ltd | Combination |
GB201616014D0 (en) * | 2016-09-20 | 2016-11-02 | Helperby Therapeutics Ltd | Combination |
GB201703898D0 (en) | 2017-03-10 | 2017-04-26 | Helperby Therapeautics Ltd | Method |
GB201704620D0 (en) | 2017-03-23 | 2017-05-10 | Helperby Therapeautics Ltd | Combinations |
GB201709193D0 (en) | 2017-06-09 | 2017-07-26 | Helperby Therapeutics Ltd | Combination |
GB201807046D0 (en) | 2018-04-30 | 2018-06-13 | Helperby Therapeutics Ltd | Combination |
GB201910787D0 (en) * | 2019-07-29 | 2019-09-11 | Helperby Therapeutics Ltd | Pharmaceutical development |
GB201910777D0 (en) * | 2019-07-29 | 2019-09-11 | Helperby Therapeutics Ltd | Analytical method |
GB201913068D0 (en) | 2019-09-10 | 2019-10-23 | Helperby Therapeutics Ltd | Combination |
GB201914847D0 (en) | 2019-10-14 | 2019-11-27 | Helperby Therapeutics Ltd | Combination |
WO2022160323A1 (zh) * | 2021-01-31 | 2022-08-04 | 兰州大学 | 核苷类似物在制备预防或治疗胃肠道疾病药物中的应用 |
CN114196586B (zh) * | 2021-12-20 | 2023-04-11 | 郑州大学 | 一株蒙氏肠球菌及其在发酵中草药中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1085352A (en) * | 1978-09-19 | 1980-09-09 | William Rossmo | Medication dispenser |
CN1102410C (zh) | 1993-10-22 | 2003-03-05 | 史密丝克莱恩比彻姆公司 | 莫匹罗星钙盐的乳膏组合物 |
ATE272717T1 (de) | 1998-11-09 | 2004-08-15 | Helperby Therapeutics Ltd | Verfahren zum screening von antibakteriellen mitteln |
WO2003011261A1 (en) | 2001-08-01 | 2003-02-13 | Medlogic Global Limited | Cyanoacrylate monomer-containing antibiotic formulation for topical use |
CN1826129A (zh) * | 2002-07-09 | 2006-08-30 | 尖端医疗有限公司 | 与异亮氨酸硼脯氨酸化合物相关的方法和组合物 |
WO2005014585A1 (en) | 2003-08-08 | 2005-02-17 | Ulysses Pharmaceutical Products Inc. | Halogenated quinazolinyl nitrofurans as antibacterial agents |
KR20070091613A (ko) | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물 |
GB0813211D0 (en) * | 2008-07-18 | 2008-08-27 | E Therapeutics Plc | Antibacterial combination therapy for the treatment of gram positive bacterial infections |
FR2936951B1 (fr) * | 2008-10-10 | 2010-12-03 | Novexel | Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments |
GB201401617D0 (en) * | 2014-01-30 | 2014-03-19 | Helperby Therapeutics Ltd | Novel combination and use |
-
2013
- 2013-03-22 GB GBGB1305277.4A patent/GB201305277D0/en not_active Ceased
-
2014
- 2014-03-20 PT PT147147730T patent/PT2976084T/pt unknown
- 2014-03-20 EP EP14714773.0A patent/EP2976084B1/en active Active
- 2014-03-20 ES ES14714773T patent/ES2795294T3/es active Active
- 2014-03-20 CA CA2906263A patent/CA2906263C/en active Active
- 2014-03-20 JP JP2016503724A patent/JP6444370B2/ja active Active
- 2014-03-20 HU HUE14714773A patent/HUE050652T2/hu unknown
- 2014-03-20 PL PL14714773T patent/PL2976084T3/pl unknown
- 2014-03-20 US US14/772,538 patent/US9757427B2/en active Active
- 2014-03-20 WO PCT/GB2014/050878 patent/WO2014147405A1/en active Application Filing
- 2014-03-20 DK DK14714773.0T patent/DK2976084T3/da active
- 2014-03-20 CN CN201480017520.1A patent/CN105120870B/zh active Active
- 2014-03-20 SI SI201431590T patent/SI2976084T1/sl unknown
-
2016
- 2016-04-21 HK HK16104568.6A patent/HK1216716A1/zh unknown
-
2020
- 2020-06-10 HR HRP20200938TT patent/HRP20200938T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
PL2976084T3 (pl) | 2021-01-25 |
JP6444370B2 (ja) | 2018-12-26 |
JP2016515542A (ja) | 2016-05-30 |
CA2906263A1 (en) | 2014-09-25 |
PT2976084T (pt) | 2020-06-16 |
HK1216716A1 (zh) | 2016-12-02 |
HRP20200938T1 (hr) | 2020-09-18 |
ES2795294T3 (es) | 2020-11-23 |
EP2976084A1 (en) | 2016-01-27 |
WO2014147405A1 (en) | 2014-09-25 |
US9757427B2 (en) | 2017-09-12 |
GB201305277D0 (en) | 2013-05-01 |
HUE050652T2 (hu) | 2020-12-28 |
DK2976084T3 (da) | 2020-06-22 |
CN105120870B (zh) | 2020-04-17 |
EP2976084B1 (en) | 2020-04-29 |
CN105120870A (zh) | 2015-12-02 |
US20160030506A1 (en) | 2016-02-04 |
CA2906263C (en) | 2020-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1216716A1 (zh) | 包含齊多夫定和多粘菌素的組合 | |
HK1221667A1 (zh) | 芳基醚及其用途 | |
AU355447S (en) | Case | |
AU354443S (en) | Case | |
AU354395S (en) | Case | |
IL240527A0 (en) | Composition of dentures and denture system | |
HK1222822A1 (zh) | 組合銳磨具組件 | |
GB201315063D0 (en) | Appliances and components therefor | |
GB201313900D0 (en) | Tumour-targeted theranostic | |
GB2514119B (en) | Rooflight assembly | |
GB201321922D0 (en) | Constructions | |
GB201307989D0 (en) | Novel combinations and use | |
SG11201600737TA (en) | Instrument changing assembly and methods | |
GB201320992D0 (en) | Complex and uses thereof | |
ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
SG11201505647YA (en) | Space aircraft | |
GB201306901D0 (en) | Combination | |
GB201311696D0 (en) | Assembly and methods | |
ZA201400517B (en) | Aircraft | |
GB201304166D0 (en) | CelebQuiff and Instant Quiff | |
GB201301393D0 (en) | Kiddibidet and pottibidet | |
GB2511577B (en) | Carrying structure | |
GB201303235D0 (en) | Rest assembly | |
GB201311534D0 (en) | Concept fifteen | |
GB201319783D0 (en) | Fingerprinting |